130 – QMSR Changes to Traceability/Reporting, Independent Reviewer & Risk Management, Learning New Regulations and MDSAP with Aaron Snyder

Podcast episode cover

April 3, 2024

130 – QMSR Changes to Traceability/Reporting, Independent Reviewer & Risk Management, Learning New Regulations and MDSAP with Aaron Snyder

[episode_spotify]

Share

Show Notes

On this episode I was joined by Aaron Snyder, VP of Quality Assurance at Allotex. Aaron discusses:

Timestamps

  • 00:58 Exploring the Impact of QMSR on Medical Device Companies
  • 02:19 UDI Regulations
  • 05:18 Understanding the FDA's Approach to QMSR and Compliance
  • 18:02 The FDA's Inspection Techniques and the Future of QMSR
  • 31:55 Where to Find Aaron and Closing Thoughts

Aaron Snyder is a quality management systems expert and is the VP of QA at Allotex. Prior to joining Allotex, Aaron served in roles at Fresenius Kabi, Molnlycke, Waters Corporation, Covidien, Cardinal Health, and General Electric. He has worked with a wide range of pharmaceuticals, medical devices and combination products. Aaron is a member of the AAMI Faculty and teaches several courses focused on various QMS topics. Aaron is also and avid content creator and dissects, presents and teaches on QMS and cGMP’s topics on his YouTube channel: Quality Systems Explained.

Join Our news Letter

By signing up, you agree to receive email from this podcast.

Recent Episodes

October 5, 2026

257 – 21 CFR Part 4 Explained: CGMP Requirements for Combination Products

September 28, 2026

256 – The New FDA Inspection Playbook: Where to Start with QMSR

September 21, 2026

255 – Audit Interview Techniques: How Good Auditors Get Better Evidence

Join Our newsletter

Sign up now to stay ahead with our combo product tips and never miss a weekly episode!

By signing up, you agree to receive email from this website.